Cargando…
Epigenetic Modulation on Tau Phosphorylation in Alzheimer's Disease
Tau hyperphosphorylation is a typical pathological change in Alzheimer's disease (AD) and is involved in the early onset and progression of AD. Epigenetic modification refers to heritable alterations in gene expression that are not caused by direct changes in the DNA sequence of the gene. Epige...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481020/ https://www.ncbi.nlm.nih.gov/pubmed/31093272 http://dx.doi.org/10.1155/2019/6856327 |
_version_ | 1783413698494201856 |
---|---|
author | Yu, Chao-Chao Jiang, Tao Yang, Ao-Fei Du, Yan-Jun Wu, Miao Kong, Li-Hong |
author_facet | Yu, Chao-Chao Jiang, Tao Yang, Ao-Fei Du, Yan-Jun Wu, Miao Kong, Li-Hong |
author_sort | Yu, Chao-Chao |
collection | PubMed |
description | Tau hyperphosphorylation is a typical pathological change in Alzheimer's disease (AD) and is involved in the early onset and progression of AD. Epigenetic modification refers to heritable alterations in gene expression that are not caused by direct changes in the DNA sequence of the gene. Epigenetic modifications, such as noncoding RNA regulation, DNA methylation, and histone modification, can directly or indirectly affect the regulation of tau phosphorylation, thereby participating in AD development and progression. This review summarizes the current research progress on the mechanisms of epigenetic modification associated with tau phosphorylation. |
format | Online Article Text |
id | pubmed-6481020 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-64810202019-05-15 Epigenetic Modulation on Tau Phosphorylation in Alzheimer's Disease Yu, Chao-Chao Jiang, Tao Yang, Ao-Fei Du, Yan-Jun Wu, Miao Kong, Li-Hong Neural Plast Review Article Tau hyperphosphorylation is a typical pathological change in Alzheimer's disease (AD) and is involved in the early onset and progression of AD. Epigenetic modification refers to heritable alterations in gene expression that are not caused by direct changes in the DNA sequence of the gene. Epigenetic modifications, such as noncoding RNA regulation, DNA methylation, and histone modification, can directly or indirectly affect the regulation of tau phosphorylation, thereby participating in AD development and progression. This review summarizes the current research progress on the mechanisms of epigenetic modification associated with tau phosphorylation. Hindawi 2019-04-10 /pmc/articles/PMC6481020/ /pubmed/31093272 http://dx.doi.org/10.1155/2019/6856327 Text en Copyright © 2019 Chao-Chao Yu et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Yu, Chao-Chao Jiang, Tao Yang, Ao-Fei Du, Yan-Jun Wu, Miao Kong, Li-Hong Epigenetic Modulation on Tau Phosphorylation in Alzheimer's Disease |
title | Epigenetic Modulation on Tau Phosphorylation in Alzheimer's Disease |
title_full | Epigenetic Modulation on Tau Phosphorylation in Alzheimer's Disease |
title_fullStr | Epigenetic Modulation on Tau Phosphorylation in Alzheimer's Disease |
title_full_unstemmed | Epigenetic Modulation on Tau Phosphorylation in Alzheimer's Disease |
title_short | Epigenetic Modulation on Tau Phosphorylation in Alzheimer's Disease |
title_sort | epigenetic modulation on tau phosphorylation in alzheimer's disease |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481020/ https://www.ncbi.nlm.nih.gov/pubmed/31093272 http://dx.doi.org/10.1155/2019/6856327 |
work_keys_str_mv | AT yuchaochao epigeneticmodulationontauphosphorylationinalzheimersdisease AT jiangtao epigeneticmodulationontauphosphorylationinalzheimersdisease AT yangaofei epigeneticmodulationontauphosphorylationinalzheimersdisease AT duyanjun epigeneticmodulationontauphosphorylationinalzheimersdisease AT wumiao epigeneticmodulationontauphosphorylationinalzheimersdisease AT konglihong epigeneticmodulationontauphosphorylationinalzheimersdisease |